We are driven and ambitious in building a scalable technology platform capable of producing consistent batches of every human cell. We are democratising access to high-quality human cells for research, drug discovery and a new generation of cures.
BBC News: Cambridge scientists aiming to make new organs from stem cells 'within a decade'
Innovation is at the core of what we do. In addition to our breakthrough technology, we harness innovation in our business practices, pricing, and partnerships to protect people and the planet. We are creating new industries and long-term opportunities.
SiP News: America is seeing huge growth in synthetic biology -- The UK must ensure it doesn’t miss out
We enable innovators to focus on what they do best, leveraging our cell coding platform to provide the cells. We are uncovering the “operating system of life”, transitioning biology to engineering, sharing genetic resources & knowledge globally, mobilising enterprise & finance on synthetic biology.
Spectator TV News: CEO and founder Mark Kotter interviewed on Spectator TV about cultured meat
bit.bio is joining the world’s efforts to tackle the climate crisis by joining the United Nations Race to Zero campaign and are committed to achieving net zero and beyond, ahead of the 2050 deadline. The commitment is part of the company’s mission to Code Cells for Health, where the business is built to do good and contribute to global sustainability from day one.
As participants of the SME Climate Hub and The Climate Pledge, who are official Race to Zero partners, bit.bio is committed to: